Biosafety
Overview
The ±«Óãtv Biosafety Program oversees the possession, use and storage of various infectious agents, recombinant deoxyribonucleic acid (rDNA), biological toxins, and select agents/toxins (commonly known as biohazardous materials) in a research and/or teaching environment.
Training Requirements for Researchers
Training in proper microbiological techniques is required for anyone working with recombinant DNA, infectious agents, select agents, and biological toxins or who works in a laboratory where these materials are used/stored. The assurance of proper training is the responsibility of the Principal Investigator (PI) or laboratory supervisor of the facility in which the hazard is used.
If you are a Principal Investigator (PI) at ±«Óãtv who possess or plans to possess, store, work with, or transport infectious agent(s), biological toxin(s), select agent(s)/toxin(s), and/or recombinant or synthetic nucleic acid molecules, you must register them with ±«Óãtv’s Institutional Biosafety Committee (IBC).
| Submission Deadline | Scheduled Meeting |
|---|---|
| December 2, 2024 | December 10, 2024 |
| Submission Deadline | Scheduled Meetings |
|---|---|
| January 13, 2025 | January 21, 2025 |
| February 17, 2025 | February 18, 2025 |
| March 10, 2025 | March 18, 2025 |
| April 7, 2025 | April 15, 2025 |
| May 12, 2025 | May 20, 2025 |
| June 9, 2025 | June 17, 2025 |
| June 30, 2025 | July 15, 2025 |
| August 11, 2025 | August 19, 2025 |
| September 8, 2025 | September 16, 2025 |
| October 13, 2025 | October 21, 2025 |
| November 10, 2025 | November 18, 2025 |
| December 1, 2025 | December 9, 2025 |
Submission Deadlines to Research Integrity & Compliance: These are the dates by which the protocol must be submitted in BiosafetyNet to be placed on that month’s meeting agenda.
±«Óãtv’s Institutional Biosafety Committee provides oversight and evaluation of research and laboratories that use biohazardous materials at ±«Óãtv and affiliated institutions to ensure they comply with ±«Óãtv IBC policy, University policy, CDC guidelines, NIH guidelines, and federal regulations , , and for select agents.
Please direct questions and comments to the Biosafety Program or Debra Howeth, telephone (813) 974-5091, fax (813) 974-7091.